These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12173613)

  • 1. Adverse reactions to dietary supplements under investigation by FDA.
    Marwick C
    BMJ; 2002 Aug; 325(7359):298. PubMed ID: 12173613
    [No Abstract]   [Full Text] [Related]  

  • 2. Another FDA warning: Kava supplements.
    Parkman CA
    Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of kava hepatotoxicity and the FDA consumer advisory.
    Teschke R; Schulze J
    JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
    [No Abstract]   [Full Text] [Related]  

  • 4. Amphetamine lacing of an Internet-marketed neutraceutical.
    Nguyen MH; Ormiston T; Kurani S; Woo DK
    Mayo Clin Proc; 2006 Dec; 81(12):1627-9. PubMed ID: 17165642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
    Jiang T
    Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Effects of Nutraceuticals and Dietary Supplements.
    Ronis MJJ; Pedersen KB; Watt J
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():583-601. PubMed ID: 28992429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplements: current FDA activities.
    Bull JC
    J Am Med Womens Assoc (1972); 1999; 54(4):199-200. PubMed ID: 10531763
    [No Abstract]   [Full Text] [Related]  

  • 11. An FDA guide to dietary supplements.
    Kurtzweil P
    FDA Consum; 1998; 32(5):28-35. PubMed ID: 9779010
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancing FDA's post-market surveillance of dietary supplements: two simple steps to build capacity.
    Lobb A
    J Diet Suppl; 2009; 6(3):204-10. PubMed ID: 22435473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA issues alert on ephedra supplements in the USA.
    Nelson R
    Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes recommended in adverse event reporting on dietary supplements.
    Landis NT
    Am J Health Syst Pharm; 2001 Jun; 58(11):948, 951, 954. PubMed ID: 11402486
    [No Abstract]   [Full Text] [Related]  

  • 15. Nutraceuticals: has there been any progress?
    Haller CA
    Clin Pharmacol Ther; 2010 Feb; 87(2):137-41. PubMed ID: 20107443
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary supplements: a call to action.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):330-2. PubMed ID: 21133740
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA faces barrage of criticism over plans to assess safety of supplements.
    Epstein K
    BMJ; 2012 Jan; 344():e583. PubMed ID: 22277134
    [No Abstract]   [Full Text] [Related]  

  • 18. Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy.
    Friedman JM
    Teratology; 2000 Aug; 62(2):134-7. PubMed ID: 10931511
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA to ban sales of dietary supplements containing ephedra.
    Ling AM
    J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
    [No Abstract]   [Full Text] [Related]  

  • 20. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.